United States

Cellumed Co Ltd (049180.KQ)

049180.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

9:25pm EST
Change (% chg)

₩35.00 (+2.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 049180.KQ


CELLUMED CO., LTD., formerly Korea Bone Bank CO.,LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Company’s products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as... (more)
No analyst recommendations are available for 049180.KQ.


Beta: 1.51
Market Cap(Mil.): ₩266,884.19
Shares Outstanding(Mil.): 181.55
Dividend: --
Yield (%): --


  049180.KQ Industry Sector
P/E (TTM): -- 33.73 30.76
EPS (TTM): -214.14 -- --
ROI: -74.41 13.22 14.89
ROE: -75.68 16.84 16.30

BRIEF-Cellumed receives patent

* Says it received U.S. patent on Oct. 31, for method for producting soft tissue homograft implanted autologous stem cell

Nov 01 2016

BRIEF-Cellumed issues 3 bln won worth of convertible bonds

* Says it completes the issuance of 3 billion won worth of convertible bonds as of Sept. 9

Sep 09 2016

BRIEF-Cellumed to issue 3 bln won worth convertible bonds

* Says it will issue the 16th unregistered/unsecured private convertible bonds, raising 3 billion won in proceeds for operations

Sep 09 2016

Earnings vs. Estimates

No consensus analysis data available.